Doctors at DHNCC apply 3D CT modeling of anatomy to better evaluate brachytherapy dose for gynecological treatments
Advanced CT imaging is giving Dharmais Hospital National Cancer Center (DHNCC) clinicians a better idea of the shape and volume of tumors and their relationship to nearby organs, improving the targeting of disease sites while minimizing the exposure to unaffected critical organs during brachytherapy treatments. Since March 2012, DHNCC physicians have used 3D CT for selected patients to contour organs-at-risk (OARs) and tumors before repeated brachytherapy treatments using the latest microSelectron® Digital remote afterloader and Oncentra® Brachy Image Guided 3D Treatment Planning system, both manufactured by Nucletron, an Elekta company.
Brachytherapy, is an advanced, highly targeted cancer treatment, in which radiotherapeutic sources are placed in or near a tumor, giving a high radiation dose to the tumor while reducing the radiation exposure to surrounding healthy tissues. DHNCC uses the newly acquired Nucletron high dose rate (HDR) brachytherapy system, which introduces the radiation source for a certain time using special applicators depending on the body site treated.
“We are pleased that we could transition to the new 3D based planning techniques, which will improve cancer care for patients in Indonesia,” says Dr. Defrizal, Head of the Radiation Therapy Department at DHNCC. “We do hope we can continue these methods for routine clinical use, and appreciate the strong support that Nucletron team specialist and has provided us.”